Clifford R. Jack

2.5k total papers · 207.5k total citations
1.2k papers, 104.7k citations indexed

About

Clifford R. Jack is a scholar working on Psychiatry and Mental health, Physiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Clifford R. Jack has authored 1.2k papers receiving a total of 104.7k indexed citations (citations by other indexed papers that have themselves been cited), including 629 papers in Psychiatry and Mental health, 471 papers in Physiology and 388 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Clifford R. Jack's work include Dementia and Cognitive Impairment Research (560 papers), Alzheimer's disease research and treatments (436 papers) and Advanced Neuroimaging Techniques and Applications (272 papers). Clifford R. Jack is often cited by papers focused on Dementia and Cognitive Impairment Research (560 papers), Alzheimer's disease research and treatments (436 papers) and Advanced Neuroimaging Techniques and Applications (272 papers). Clifford R. Jack collaborates with scholars based in United States, United Kingdom and Germany. Clifford R. Jack's co-authors include Ronald C. Petersen, David S. Knopman, Michael W. Weiner, Bradley F. Boeve, Prashanthi Vemuri, Matthew L. Senjem, Stephen D. Weigand, John Q. Trojanowski, William J. Jagust and Philip Scheltens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Clifford R. Jack

1.1k papers receiving 102.9k citations

Hit Papers

The diagnosis of dementia... 1989 2026 2001 2013 2011 2009 2013 2009 2010 4.0k 8.0k 12.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    2011 13.7k citations David S. Knopman, Clifford R. Jack et al. Alzheimer s & Dementia profile →
  2. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
    2009 3.4k citations Clifford R. Jack, David S. Knopman et al. The Lancet Neurology profile →
  3. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
    2013 3.1k citations Clifford R. Jack, David S. Knopman et al. The Lancet Neurology profile →
  4. Alzheimer's Disease Neuroimaging Initiative (ADNI)
    2009 1.6k citations Ronald C. Petersen, Paul Aisen et al. Neurology profile →
  5. The clinical use of structural MRI in Alzheimer disease
    2010 1.4k citations Giovanni B. Frisoni, Nick C. Fox et al. Nature Reviews Neurology profile →
  6. Introduction to the recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    2011 1.3k citations Clifford R. Jack, David S. Knopman et al. Alzheimer s & Dementia profile →
  7. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
    2016 1.2k citations Clifford R. Jack, David A. Bennett et al. Neurology profile →
  8. Mild Cognitive Impairment
    2009 1.1k citations Ronald C. Petersen, Rosebud O. Roberts et al. Archives of Neurology profile →
  9. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
    1999 1.1k citations Clifford R. Jack, Ronald Petersen et al. Neurology profile →
  10. The Alzheimer's Disease Neuroimaging Initiative
    2005 968 citations Susanne G. Mueller, Michael W. Weiner et al. Neuroimaging Clinics of North America profile →
  11. Automatic classification of MR scans in Alzheimer's disease
    2008 872 citations Stefan Klöppel, Cynthia M. Stonnington et al. Brain profile →
  12. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
    1997 855 citations Clifford R. Jack, Ronald C. Petersen et al. Neurology profile →
  13. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
    2009 821 citations Clifford R. Jack, Val J. Lowe et al. Brain profile →
  14. Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI)
    2005 812 citations Susanne G. Mueller, Michael W. Weiner et al. Alzheimer s & Dementia profile →
  15. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
    2008 756 citations Clifford R. Jack, Val J. Lowe et al. Brain profile →
  16. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception
    2013 696 citations Michael W. Weiner, Dallas P. Veitch et al. Alzheimer s & Dementia profile →
  17. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
    2024 691 citations Clifford R. Jack, Ana Graf et al. Alzheimer s & Dementia profile →
  18. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD
    2000 688 citations Clifford R. Jack, Ronald C. Petersen et al. Neurology profile →
  19. Biomarker Modeling of Alzheimer’s Disease
    2013 681 citations Clifford R. Jack, David M. Holtzman Neuron profile →
  20. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease
    1992 676 citations Clifford R. Jack, Ronald C. Petersen et al. Neurology profile →
  21. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD
    2004 629 citations Clifford R. Jack, Maria M. Shiung et al. Neurology profile →
  22. Defining imaging biomarker cut points for brain aging and Alzheimer's disease
    2016 578 citations Clifford R. Jack, Heather J. Wiste et al. Alzheimer s & Dementia profile →
  23. Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer Disease
    2010 553 citations Joseph F. Quinn, Rema Raman et al. JAMA profile →
  24. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
    2011 543 citations Reisa A. Sperling, Clifford R. Jack et al. Alzheimer s & Dementia profile →
  25. Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults.
    1989 517 citations Clifford R. Jack, Colleen Twomey et al. Radiology profile →
  26. An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer disease
    2011 468 citations Clifford R. Jack, David S. Knopman et al. Annals of Neurology profile →
  27. Testing the Right Target and Right Drug at the Right Stage
    2011 409 citations Reisa A. Sperling, Clifford R. Jack et al. profile →
  28. Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography
    2018 405 citations Michelle M. Mielke, Clinton E. Hagen et al. Alzheimer s & Dementia profile →
  29. On the path to 2025: understanding the Alzheimer’s disease continuum
    2017 362 citations Paul Aisen, Jeffrey L. Cummings et al. Alzheimer s Research & Therapy profile →
  30. Cascading network failure across the Alzheimer’s disease spectrum
    2015 356 citations David T. Jones, David S. Knopman et al. Brain profile →
  31. An autoradiographic evaluation of AV-1451 Tau PET in dementia
    2016 345 citations Val J. Lowe, Geoffry L. Curran et al. Acta Neuropathologica Communications profile →
  32. Drug development in Alzheimer’s disease: the path to 2025
    2016 344 citations Jeffrey L. Cummings, Paul Aisen et al. Alzheimer s Research & Therapy profile →
  33. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
    2018 324 citations Dallas P. Veitch, Michael W. Weiner et al. Alzheimer s & Dementia profile →
  34. Longitudinal tau PET in ageing and Alzheimer’s disease
    2018 286 citations Clifford R. Jack, Heather J. Wiste et al. Brain profile →
  35. Performance of plasma phosphorylated tau 181 and 217 in the community
    2022 238 citations Michelle M. Mielke, Ryan D. Frank et al. profile →
  36. Developing the ATX(N) classification for use across the Alzheimer disease continuum
    2021 200 citations Harald Hampel, Jeffrey L. Cummings et al. Nature Reviews Neurology profile →
  37. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes
    2021 146 citations Michelle M. Mielke, Ryan D. Frank et al. profile →
  38. Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
    2023 77 citations Jeremiah A. Aakre, Vijay K. Ramanan et al. Neurology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Clifford R. Jack 53.4k 46.0k 29.8k 22.9k 16.0k 1.2k 104.7k
Ronald C. Petersen 60.9k 1.1× 51.2k 1.1× 29.2k 1.0× 14.3k 0.6× 18.1k 1.1× 1.1k 116.2k
Philip Scheltens 43.7k 0.8× 36.3k 0.8× 29.7k 1.0× 16.2k 0.7× 18.1k 1.1× 1.2k 99.9k
John C. Morris 47.8k 0.9× 43.9k 1.0× 24.6k 0.8× 11.1k 0.5× 15.0k 0.9× 999 115.5k
David S. Knopman 47.1k 0.9× 40.7k 0.9× 22.9k 0.8× 11.3k 0.5× 14.7k 0.9× 1.0k 93.3k
Michael W. Weiner 30.6k 0.6× 27.7k 0.6× 19.9k 0.7× 16.8k 0.7× 10.4k 0.7× 889 70.9k
Bruce L. Miller 31.8k 0.6× 28.8k 0.6× 28.7k 1.0× 9.4k 0.4× 12.3k 0.8× 1.1k 90.0k
William J. Jagust 32.3k 0.6× 27.8k 0.6× 20.2k 0.7× 10.5k 0.5× 9.7k 0.6× 480 61.0k
Bradley T. Hyman 24.2k 0.5× 60.4k 1.3× 18.3k 0.6× 9.0k 0.4× 21.0k 1.3× 728 113.5k
Frederik Barkhof 17.2k 0.3× 12.8k 0.3× 17.6k 0.6× 21.0k 0.9× 11.4k 0.7× 1.4k 88.3k
Kaj Blennow 41.1k 0.8× 65.5k 1.4× 10.4k 0.3× 6.7k 0.3× 22.0k 1.4× 2.0k 121.6k

Countries citing papers authored by Clifford R. Jack

Since Specialization
Citations

This map shows the geographic impact of Clifford R. Jack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clifford R. Jack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clifford R. Jack more than expected).

Fields of papers citing papers by Clifford R. Jack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clifford R. Jack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clifford R. Jack. The network helps show where Clifford R. Jack may publish in the future.

Co-authorship network of co-authors of Clifford R. Jack

This figure shows the co-authorship network connecting the top 25 collaborators of Clifford R. Jack. A scholar is included among the top collaborators of Clifford R. Jack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clifford R. Jack. Clifford R. Jack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Levy Breakdown of academic impact, for papers by Peng Shi Breakdown of academic impact, for papers by Guanrong Chen Breakdown of academic impact, for papers by Gordon Guyatt Breakdown of academic impact, for papers by Nicholas G. Martin Breakdown of academic impact, for papers by Mark Woodward Breakdown of academic impact, for papers by Valentı́n Fuster Breakdown of academic impact, for papers by Michaël Maes
Rankless by CCL
2026